Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02702180
Brief Title: Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (IMPALA)

First Submitted : February 28, 2016
First Submitted that Met QC Criteria : March 2, 2016
First Posted : March 8, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 18, 2019
Last Update Posted : September 19, 2019